Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.

NCT07266480 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Squamous Oesophageal Cancer

Interventions

DRUG: Adebrelizumab

Sponsor

Hebei Medical University Fourth Hospital